Mesothelioma Information   SUBMIT


  close
Dr Alley talks to ecancertv at AACR 2015 about the results of a phase I multi-centre trial looking at the use of pembrolizumab in the treatment of a variety of cancers. The drug showed signs of clinical benefit in patients with malignant pleural mesothelioma.